Renal function estimation formulas in predicting long-term cardiovascular outcomes in patients with myocardial infarction concurrent with diabetes mellitus

Abstract


Aim. To comparatively assess formulas for estimating glomerular filtration rate (GFR) in the prediction of poor outcomes in patients with type 2 diabetes mellitus (DM) within one year after myocardial infarction (MI). Subjects and methods. The investigators examined 89 patients with ST-segment elevation myocardial infarction (STEMI) within 24 hours after the onset of clinical symptoms of the disease. All the patients underwent standard laboratory and instrumental tests. GFR was calculated using the Modified of Diet in Renal Diseases (MDRD) formulas in terms of serum creatinine levels, the Hoek equation: GFR [ml/min/1.73 m2] = (80.35/cystatin C [mg/l]) — 4.3 (CKD-EPI), as well as from cystatin C levels, and the creatinine clearance rate was determined using the Cockcroft and Gault formula (ml/min). During a year after STEMI, the investigators recorded cardiovascular events (CVEs), such as death, recurrent MI, progressive angina pectoris, emergency coronary revascularization, and decompensated chronic heart failure (CHF). The examinees were divided into two groups: 1) 70 (78.6%) patients with MI and no DM; 2) 19 (21.3%) patients with MI and DM. Results. Comparative analysis revealed a tendency towards a difference in the detection rate of GFR <60 ml/min/1.73 m2 calculated using the Hoek formula from cystatin C levels: 42.1% in Group 2 and 21.4% in Group 1 (р=0.067). There were no great differences in the GFR estimated using other formulas. Logistic regression analysis was carried out to determine the most sensitive formula for estimating GFR to assess the risk of CVEs in the patients within a year after MI concurrent with and without type 2 DM. A univariate analysis showed that GFR calculations using the CKD-EPI (odds ratio (OR), 13.5; p=0.046) and MDRD (OR, 6.5; р=0.040) formulas and creatinine clearance estimation (OR, 2.4; p=0.025) were most sensitive in selecting MI patients without DM and with poor outcomes. This analysis revealed that GFR estimates using the Hoek formula from cystatin C levels (OR, 6.15; p=0.018) were most sensitive for patients with MI concurrent with type 2 DM. In both models, multivariate analysis included none of the analyzed indicators. Conclusion. To estimate cardiovascular risk in the long-term post-infarction period, the CKD-EPI formula in the patients without type 2 DM and the Hoek formula from cystatin C levels were noted to be of the greatest prognostic value in patients with DM.

References

  1. Parving H, Brenner B, McMurray J, de Zeeuw D, Haffner S, Solomon S, Chaturvedi N, Persson F, Desai A, Nicolaides M, Richard A, Xiang Z, Brunel P, Pfeffer M. Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes. New Engl J Med. 2012;367(23):2204-2213. doi: 10.1056/nejmoa1208799.
  2. Bart B, Goldsmith S, Lee, K, Givertz M, O’Connor C, Bull D, Redfield M, Deswal A, Rouleau J, LeWinter M, Ofili E, Stevenson L, Semigran M, Felker G, Chen H, Hernandez A, Anstrom K, McNulty S, Velazquez E, Ibarra J, Mascette A, Braunwald E. Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome. New Engl J Med. 2012;367(24):2296-2304. doi: 10.1056/nejmoa1210357.
  3. Mann J, Schmieder R, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsärinne K, Oto A, Parkhomenko A, Piegas L, Svendsen T, Teo K, Yusuf S. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet. 2008;372(9638):547-553. doi: 10.1016/s0140-6736(08)61236-2.
  4. Смирнов А.В., Каюков И.Г., Есаян А.М., Кучер А.Г., Дегтерева О.А. Проблема оценки скорости клубочковой фильтрации в современной нефрологии: новый индикатор-Цистатин С. Нефрология. 2005;3(9):16-27.
  5. Рабочая группа Научного общества нефрологов России. Национальные рекомендации. Хроническая болезнь почек основные положения, определение, диагностика, скрининг, подходы к профилактике и лечению. Доступно по: http://journal.nephrolog.ru/ckd.
  6. Барбараш О.Л., Зыков М.В., Быкова И.С., Кашталап В.В., Каретникова В.Н., Барбараш Л.С. Роль дисфункции почек и мультифокального атеросклероза в оценке прогноза у больных инфарктом миокарда и подъемом сегмента ST. Кардиология. 2013;9:26-32.
  7. Matsushita K, Selvin E, Bash L, Franceschini N, Astor B, Coresh J. Change in Estimated GFR Associates with Coronary Heart Disease and Mortality. J Am Soc Nephrol. 2009;20(12):2617-2624. doi: 10.1681/asn.2009010025.
  8. Taglieri N, Koenig W, Kaski J. Cystatin C and Cardiovascular Risk. Clin Chem. 2009;55(11):1932-1943. doi: 10.1373/clinchem.2009.128397.
  9. Кобалава Ж.Д., Виллевальде С.В., Моисеев В.С. Значение различных методов оценки функционального состояния почек для стратификации сердечно-сосудистого риска. Кардиология. 2007;12:74-80.
  10. Мухин Н.А. Пропедевтика внутренних болезней: учеб. с прил. на компакт-диске для студентов мед. вузов. Мухин Н.А., Моисеев В.С. 2-е изд., доп. и перераб. М.: ГЭОТАР-Медиа; 2007.
  11. Авдошина С.В., Пигарева Ю.А., Виллевальде С.В., Ежова Л.Г., Кобалава Ж.Д. Распространенность, варианты и прогностическое значение острого почечного повреждения у больных с острым коронарным синдромом без подъема сегмента ST. Клиническая фармакология и терапия. 2013;3:30-36.
  12. Patel P, Ayers C, Murphy S, Peshock R, Khera A, de Lemos J, Balko J, Gupta S, Mammen P, Drazner M, Markham D. Association of Cystatin C With Left Ventricular Structure and Function: The Dallas Heart Study. Circulation: Heart Failure. 2009;2(2): 98-104. doi: 10.1161/circheartfailure.108.807271.
  13. Tidman M, Sjostrom P, Jones I. A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two. Nephrol Dial Transplant. 2007;23(1):154-160. doi: 10.1093/ndt/gfm661.
  14. Оганезова Л.Г. Скорость клубочковой фильтрации: что должен о ней знать кардиолог. Кардиология сегодня. 2012;1(2):7-8. Доступно по: http://www.scardio.ru/content/images/documents/KS__1_2012-web116.file.pdf.
  15. Foley R. Chronic Kidney Disease and the Risk for Cardiovascular Disease, Renal Replacement, and Death in the United States Medicare Population, 1998 to 1999. J Am Soc Nephrol. 2005;16(2): 489-495. doi: 10.1681/asn.2004030203.
  16. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731): 2073-2081. doi: 10.1016/s0140-6736(10)60674-5.

Statistics

Views

Abstract - 97

PDF (Russian) - 21

Cited-By


Article Metrics

Metrics Loading ...

Refbacks

  • There are currently no refbacks.

Copyright (c) 2020 Karetnikova V.N., Osokina A.V., Evseeva M.V., Kalaeva V.V., Gruzdeva O.V., Kashtalap V.V., Zykov M.V., Avramenko O.E., Barbarash O.L.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:

 

© 2018 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies